In vitro and in vivo activities of this novel GSK-3β inhibitors was demonstrated by Khanfar et al.59 Dysfunctioning of GSK-3β is involved in the pathophysiology of many diseases such as type 2 diabetes mellitus, stroke, Alzheimer, and other related diseases. Here, GSK3B is linked to diabetes mellitus.